MiR-21 expression in the tumor cell compartment holds unfavorable prognostic value in gliomas

Journal of Neuro-Oncology

Volumn 111, Issue 1, 2013, Pages 71-81

  Hermansen, Simon Kjær ^a,b   Dahlrot, Rikke Hedegaard ^a,b   Nielsen, Boye Schnack ^c,d   Hansen, Steinbjørn ^a,b   Kristensen, Bjarne Winther ^a,b  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

^b UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^c Exiqon AS   (Denmark)

^d BIONEER A S   (Denmark)

Author keywords

Glioma; In situ hybridization; LNA; miR 21; miRNA; Prognosis

Indexed keywords

MICRORNA 21;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER GRADING; CANCER MORPHOLOGY; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER SURVIVAL; CARCINOGENESIS; CELL COMPARTMENTALIZATION; DISEASE MARKER; FEMALE; GENE LOCATION; GLIOBLASTOMA; GLIOMA; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PILOCYTIC ASTROCYTOMA; QUANTITATIVE ANALYSIS; SEX DIFFERENCE;

BRAIN NEOPLASMS; DNA PROBES; FEMALE; GENE EXPRESSION PROFILING; GLIOMA; HUMANS; IN SITU HYBRIDIZATION; MALE; MICRORNAS; MIDDLE AGED; NEOPLASM GRADING; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OLIGONUCLEOTIDES; PROGNOSIS; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 84871787992     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-012-0992-3     Document Type: Article

References (45)

1. Louis DN, Ohgaki H, Wiestler OD et al. (2007) WHO classification of tumours of the central nervous system. 4th edn. International Agency for Research on Cancer (IARC), Lyon
2. Stupp R, Mason WP, van den Bent MJ et al (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352:987-996
3. Stupp R, Hegi ME, Mason WP et al (2009) Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol 10:459-466
4. Friedman RC, Farh KK, Burge CB et al (2009) Most mammalian mRNAs are conserved targets of microRNAs. Genome Res 19:92-105
5. Croce CM (2009) Causes and consequences of microRNA dysregulation in cancer. Nat Rev Genet 10:704-714
6. Zhi F, Chen X, Wang S et al (2010) The use of hsa-miR-21, hsa-miR-181b and hsa-miR-106a as prognostic indicators of astrocytoma. Eur J Cancer 46:1640-1649
7. Visone R, Croce CM (2009) miRNAs and cancer. Am J Pathol 174:1131-1138
8. Selcuklu SD, Donoghue MT, Spillane C (2009) miR-21 as a key regulator of oncogenic processes. Biochem Soc Trans 37:918-925
9. Chen Y, Liu W, Chao T et al (2008) MicroRNA-21 down-regulates the expression of tumor suppressor PDCD4 in human glioblastoma cell T98G. Cancer Lett 272:197-205
10. Lu Z, Liu M, Stribinskis V et al (2008) MicroRNA-21 promotes cell transformation by targeting the programmed cell death 4 gene. Oncogene 27:4373-4379
11. Frankel LB, Christoffersen NR, Jacobsen A et al (2008) Programmed cell death 4 (PDCD4) is an important functional target of the microRNA miR-21 in breast cancer cells. J Biol Chem 283:1026-1033
12. Pan Q, Luo X, Chegini N (2010) microRNA 21: response to hormonal therapies and regulatory function in leiomyoma, transformed leiomyoma and leiomyosarcoma cells. Mol Hum Reprod 16:215-227
13. Zhu S, Si ML, Wu H et al (2007) MicroRNA-21 targets the tumor suppressor gene tropomyosin 1 (TPM1). J Biol Chem 282:14328-14336
14. Kwak HJ, Kim YJ, Chun KR et al (2011) Downregulation of Spry2 by miR-21 triggers malignancy in human gliomas. Oncogene 30:2433-2442
15. Qian B, Katsaros D, Lu L et al (2009) High miR-21 expression in breast cancer associated with poor disease-free survival in early stage disease and high TGF-beta1. Breast Cancer Res Treat 117:131-140
16. Yan LX, Huang XF, Shao Q et al (2008) MicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis. RNA 14:2348-2360
17. Schetter AJ, Leung SY, Sohn JJ et al (2008) MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma. JAMA 299:425-436
18. Nielsen BS, Jørgensen S, Fog JU et al (2011) High levels of microRNA-21 in the stroma of colorectal cancers predict short disease-free survival in stage II colon cancer patients. Clin Exp Metastasis 28:27-38
19. Spahn M, Kneitz S, Scholz CJ et al (2010) Expression of microRNA-221 is progressively reduced in aggressive prostate cancer and metastasis and predicts clinical recurrence. Int J Cancer 127:394-403
20. Markou A, Tsaroucha EG, Kaklamanis L et al (2008) Prognostic value of mature microRNA-21 and microRNA-205 overexpression in non-small cell lung cancer by quantitative real-time RT-PCR. Clin Chem 54:1696-1704
21. Avissar M, McClean MD, Kelsey KT et al (2009) MicroRNA expression in head and neck cancer associates with alcohol consumption and survival. Carcinogenesis 30:2059-2063
22. Li J, Huang H, Sun L et al (2009) MiR-21 indicates poor prognosis in tongue squamous cell carcinomas as an apoptosis inhibitor. Clin Cancer Res 15:3998-4008
23. Conti A, Aguennouz M, La TD et al (2009) miR-21 and 221 upregulation and miR-181b downregulation in human grade II-IV astrocytic tumors. J Neurooncol 93:325-332
24. Shi L, Chen J, Yang J et al (2010) MiR-21 protected human glioblastoma U87MG cells from chemotherapeutic drug temozolomide induced apoptosis by decreasing Bax/Bcl-2 ratio and caspase-3 activity. Brain Res 1352:255-264
25. Chan JA, Krichevsky AM, Kosik KS (2005) MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Res 65:6029-6033
26. Rao SA, Santosh V, Somasundaram K (2010) Genome-wide expression profiling identifies deregulated miRNAs in malignant astrocytoma. Mod Pathol 23:1404-1417
27. Sulman EP, Aldape K (2011) The use of global profiling in biomarker development for gliomas. Brain Pathol 21:88-95
28. Colman H, Zhang L, Sulman EP et al (2010) A multigene predictor of outcome in glioblastoma. Neuro Oncol 12:49-57
29. Jørgensen S, Baker A, Møller S et al (2010) Robust one-day in situ hybridization protocol for detection of microRNAs in paraffin samples using LNA probes. Methods 52:375-381
30. Rask L, Balslev E, Jørgensen S et al (2011) High expression of miR-21 in tumor stroma correlates with increased cancer cell proliferation in human breast cancer. APMIS 119:663-673
31. Yamamichi N, Shimomura R, Inada K et al (2009) Locked nucleic acid in situ hybridization analysis of miR-21 expression during colorectal cancer development. Clin Cancer Res 15:4009-4016
32. Fassan M, Pizzi M, Giacomelli L et al (2011) PDCD4 nuclear loss inversely correlates with miR-21 levels in colon carcinogenesis. Virchows Arch 458:413-419
33. Sempere LF, Preis M, Yezefski T et al (2010) Fluorescence-based codetection with protein markers reveals distinct cellular compartments for altered MicroRNA expression in solid tumors. Clin Cancer Res 16:4246-4255
34. Qi L, Bart J, Tan LP et al (2009) Expression of miR-21 and its targets (PTEN, PDCD4, TM1) in flat epithelial atypia of the breast in relation to ductal carcinoma in situ and invasive carcinoma. BMC Cancer 9:163
35. Sempere LF, Christensen M, Silahtaroglu A et al (2007) Altered MicroRNA expression confined to specific epithelial cell subpopulations in breast cancer. Cancer Res 67:11612-11620
36. du Rieu MC, Torrisani J, Selves J et al (2010) MicroRNA-21 is induced early in pancreatic ductal adenocarcinoma precursor lesions. Clin Chem 56:603-612
37. Dyrskjøt L, Ostenfeld MS, Bramsen JB et al (2009) Genomic profiling of microRNAs in bladder cancer: miR-129 is associated with poor outcome and promotes cell death in vitro. Cancer Res 69:4851-4860
38. Voellenkle C, van Rooij J, Guffanti A et al (2012) Deep-sequencing of endothelial cells exposed to hypoxia reveals the complexity of known and novel microRNAs. RNA 18:472-484
39. Kuehbacher A, Urbich C, Zeiher AM et al (2007) Role of Dicer and Drosha for endothelial microRNA expression and angiogenesis. Circ Res 101:59-68
40. Suarez Y, Fernandez-Hernando C, Pober JS et al (2007) Dicer dependent microRNAs regulate gene expression and functions in human endothelial cells. Circ Res 100:1164-1173
41. Liao JY, Ma LM, Guo YH et al (2010) Deep sequencing of human nuclear and cytoplasmic small RNAs reveals an unexpectedly complex subcellular distribution of miRNAs and tRNA 3′ trailers. PLoS ONE 5:e10563
42. Gravgaard KH, Lyng MB, Laenkholm AV et al (2012) The miRNA-200 family and miRNA-9 exhibit differential expression in primary versus corresponding metastatic tissue in breast cancer. Breast Cancer Res Treat 134:207-217
43. Hwang HW, Wentzel EA, Mendell JT (2007) A hexanucleotide element directs microRNA nuclear import. Science 315:97-100
44. Place RF, Li LC, Pookot D et al (2008) MicroRNA-373 induces expression of genes with complementary promoter sequences. Proc Natl Acad Sci USA 105:1608-1613
45. Kim DH, Saetrom P, Snove O Jr et al (2008) MicroRNA-directed transcriptional gene silencing in mammalian cells. Proc Natl Acad Sci USA 105:16230-16235